The role of radical surgery followed by adjuvant therapy for high-risk early-stage cervical carcinoma patients with pelvic lymph node metastasis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 93, Issue 1, 2000, Pages 85-90

  Lin, Hao ^a   Changchien, Chan Chao ^a   Huang, Eng Yen ^a   Eng, Hock Liew ^a   Huang, Chao Chan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cervical cancer; Lymph node metastasis; Radical surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA;

EID: 0033801512     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00268-2     Document Type: Article

References (29)

1. Shingleton H.M., Gore H., Soong S.J., Orr J.W. Jr., Hatch K.D., Austin J.M., Partridge E.E. Tumor recurrence and survival in stage Ib cancer of the cervix. Am J Clin Oncol. 6:1983;265-272.
2. Noguchi H., Shiozawa I., Sakai Y., Yamazsaki T., Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol. 27:1987;150-158.
3. Russell A.H., Tong D.Y., Figge D.C., Tamimi H.K., Greer B.E., Elder S.J. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomy. Int J Radiat Oncol Biol Phys. 10:1984;211-214.
4. Larson D.M., Stringer C.A., Copeland L.J., Gershenson D.M., Malone J.M., Rutledge F.N. Stage Ib cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapy. Obstet Gynecol. 69:1987;378-381.
5. Lai C.H., Lin T.S., Soong Y.K., Chen H.F. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 35:1989;193-198.
6. Tinga D.J., Timmer P.R., Bouma J., Aalders J.G. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage Ib. Gynecol Oncol. 39:1990;175-180.
7. Lin H., Changchien C.C., Chang S.Y., Leung S.W. Survival advantages and complications of adjuvant therapy in early-stage cervical cancer with pelvic node metastasis. Chang Gung Med J. 21:1998;383-390.
8. Potter M.E., Alvarez R.D., Shingleton H.M., Soong S.J., Hatch K.D. Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy? Gynecol Oncol. 37:1990;78-81.
9. Hedley D.W., Friedlander M.L., Taylor I.W. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry. 6:1985;327-333.
10. Jakobsen A. Prognostic impact of ploidy level in carcinoma of cervix. Am J Clin Oncol. 7:1984;475-480.
11. Lai C.H., Hsueh S., Huang M.Y., Chang M.F., Soong Y.K. The uses and limitations of DNA flow cytometry in stage Ib or II cervical carcinoma. Cancer. 72:1993;3655-3662.
12. Kenter G.G., Cornelisse C.J., Aartsen E.J., Mooy W., Hermans J., Heintz A.P.M., Fleuren G.J. DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix. Gynecol Oncol. 39:1990;181-185.
13. Kristensen G.B., Kaern J., Abeler V.M., Hagmar B., Trope C.G., Pettersen E.O. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients. Gynecol Oncol. 57:1995;79-85.
14. Strang P., Eklund G., Stendahl U., Frankendal B. S phase rate as a predictor of early recurrences in carcinoma of the uterine cervix. Anticancer Res. 7:1987;807-810.
15. Deitch A.D., White R.D.V., Madewell B.R. False DNA aneuploidy in canine and human neoplasms. Anticancer Res. 13:1993;2117-2118.
16. Jacobsen A.B., Fossa S.D., Thorud E., Lunde S., Melvik J.E., Pettersen E.O. DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material. APMIS. 96:1988;25-29.
17. Connor J.P., Miller D.S., Bauer K.D., Murad T.M., Rademaker A.W., Lurain J.R. Flow cytometric evaluation of early invasive cervical cancer. Obstet Gynecol. 81:1993;367-371.
18. Joensuu H., Kallioniemi O.P. Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry. 10:1989;711-717.
19. Scambia G., Panici P.B., Baiocchi B., Amoroso M., Foti E., Greggi S., Mancuso S. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy. Am J Obstet Gynecol. 164:1991;631-636.
20. Maiman M., Feuer G., Fruchter R.G., Shaw N., Boyce J. Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma. Gynecol Oncol. 34:1989;312-316.
21. Dodd J.K., Henry R.J.W., Tyler J.P.P., Houghton C.R.S. A comparison of four potential biochemical tumor markers. Gynecol Oncol. 32:1989;248-252.
22. Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 40:1977;1621-1628.
23. Kato H., Morioka H., Tsutsui H., Aramaki S., Torigoe T. Value of tumor antigen (TA-4) of squamous cell carcinoma antigen in predicting the extent of cervical cancer. Cancer. 50:1982;1294-1296.
24. Ngan H.Y., Cheung A.N., Lauder I.J., Cheng D.K., Wong L.C., Ma H.K. Tumor markers and their prognostic value in adenocarcinoma of the cervix. Tumour Biol. 19:1998;439-444.
25. Duk J.M., Aalders J.G., Fleuren G.J., Krans M., De Bruijn H.W. Tumor markers CA125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol. 73:1989;661-668.
26. Verlooy H., Devos P., Janssens J., Mortelmans L., Gerits M., Bonte J., De Roo M. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125. Gynecol Obstet Invest. 32:1991;55-58.
27. Patsner B., Orr J.W. Jr., Allmen T. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix? Obstet Gynecol. 75:1989;786-788.
28. Bolger B.S., Dabbas M., Lopes A., Monaghan J.M. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol. 65:1997;309-313.
29. Takeshima N., Hirai Y., Katase K., Yano K., Yamauchi K., Hasumi K. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol. 68:1998;263-266.